BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31336124)

  • 1. Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.
    Hindryckx P; Jairath V; Zou G; Feagan BG; Sandborn WJ; Stoker J; Khanna R; Stitt L; van Viegen T; Shackelton LM; Taylor SA; Santillan C; Mearadji B; D'Haens G; Richard MP; Panes J; Rimola J
    Gastroenterology; 2019 Nov; 157(5):1233-1244.e5. PubMed ID: 31336124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
    van Rijn KL; Meima-van Praag EM; Bossuyt PM; D'Haens GR; Gecse KB; Horsthuis K; Snijder HJ; Tielbeek JAW; Buskens CJ; Stoker J
    J Crohns Colitis; 2022 Jun; 16(5):708-716. PubMed ID: 34644395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a magnetic resonance imaging index for fistulising Crohn's disease.
    Samaan MA; Puylaert CAJ; Levesque BG; Zou GY; Stitt L; Taylor SA; Shackelton LM; Vandervoort MK; Khanna R; Santillan C; Rimola J; Hindryckx P; Nio CY; Sandborn WJ; D'Haens G; Feagan BG; Jairath V; Stoker J
    Aliment Pharmacol Ther; 2017 Sep; 46(5):516-528. PubMed ID: 28653753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
    Crowley E; Ma C; Guizzetti L; Zou G; Lewindon PJ; Gee MS; Hyams JS; Rosen MJ; von Allmen D; de Buck van Overstraeten A; Shackelton LM; Remillard J; Schleicher L; Dillman JR; Rimola J; Taylor SA; Fletcher JG; Church PC; Feagan BG; Griffiths AM; Jairath V; Greer MC
    Inflamm Bowel Dis; 2024 Mar; 30(3):357-369. PubMed ID: 37524088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoring Indices for Perianal Fistulising Crohn's Disease: A Systematic Review.
    Vuyyuru SK; Solitano V; Singh S; Hanzel J; Macdonald JK; Danese S; Peyrin Biroulet L; Ma C; Jairath V
    J Crohns Colitis; 2024 Jun; 18(6):836-850. PubMed ID: 38126903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the
    Greer MC; Taylor SA
    AJR Am J Roentgenol; 2022 May; 218(5):781-792. PubMed ID: 34549607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn's disease?
    Richard N; Derinck A; Bridoux V; Charpentier C; Savoye Collet C; Savoye G
    Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38512515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
    Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
    Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and MRI Evolution After Local Injection of Bone Marrow-Derived Mesenchymal Stem Cells in Perianal Fistulae in Crohn's Disease: Results From a Prospective Monocentric Study.
    Reenaers C; Gillard RP; Coimbra C; Gillard RM; Meunier P; Lechanteur C; Baudoux E; Boutaffala L; Beguin Y; Louis É
    J Crohns Colitis; 2023 May; 17(5):728-737. PubMed ID: 36733215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
    McCurdy JD; Munir J; Parlow S; Reid J; Yanofsky R; Alenezi T; Meserve J; Becker B; Lahijanian Z; Eddin AH; Mallick R; Ramsay T; Rosenfeld G; Bessissow A; Bessissow T; Jairath V; Singh S; Bruining DH; Macdonald B;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1058-1066.e2. PubMed ID: 38122958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.
    Singh A; Kakkar C; Garg S; Arora K; Midha V; Mahajan R; Virk SS; Jain NP; Singh D; Sood K; Tripathi A; Gupta D; Kaushal IG; Galhotra RD; Saggar K; Sood A
    Indian J Gastroenterol; 2023 Oct; 42(5):668-676. PubMed ID: 37548863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy.
    Savoye-Collet C; Savoye G; Koning E; Dacher JN; Lerebours E
    Inflamm Bowel Dis; 2011 Aug; 17(8):1751-8. PubMed ID: 21744430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-screening questionnaire for perianal fistulizing disease in patients with Crohn's disease.
    Kweon OS; Kang B; Lee YJ; Kim ES; Kim SK; Lee HS; Chung YJ; Kim KO; Jang BI;
    Korean J Intern Med; 2024 May; 39(3):430-438. PubMed ID: 38576234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Diez MC; Tagarro I; Leselbaum A; Danese S;
    Gastroenterology; 2018 Apr; 154(5):1334-1342.e4. PubMed ID: 29277560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization transfer ratio for the assessment of perianal fistula activity in Crohn's disease.
    Pinson C; Dolores M; Cruypeninck Y; Koning E; Dacher JN; Savoye G; Savoye-Collet C
    Eur Radiol; 2017 Jan; 27(1):80-87. PubMed ID: 27085695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.